Q2 Earnings Forecast for TG Therapeutics Issued By B. Riley
TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Equities research analysts at B. Riley issued their Q2 2025 earnings per share estimates for TG Therapeutics in a research note issued on Tuesday, March 4th. B. Riley analyst M. Mamtani anticipates that the biopharmaceutical company will post earnings per share of $0.27 for the quarter. The […]
TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Equities research analysts at B. Riley issued their Q2 2025 earnings per share estimates for TG Therapeutics in a research note issued on Tuesday, March 4th. B. Riley analyst M. Mamtani anticipates that the biopharmaceutical company will post earnings per share of $0.27 for the quarter. The […]
